Articles

CureVac announced positive results for its mRNA-based Covid-19 and flu vaccine, which may offer tremendous relevance for CVAC stock. More

Three insiders, including CEO Jason Robins, have acquired a total of more than one million shares of DKNG stock since December. More

CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock. More

Biogen is in focus today with the company's lecanemab drug set for an FDA decision on approval, leading to bullish bets on BIIB stock. More

The number of cheap stocks Wall Street analysts love might have gone down over the past year, but there are still plenty of options. More

Some investors in embattled retailer Bed Bath & Beyond and BBBY stock are pricing in the potential for Ryan Cohen to join the fray once again. More

As stocks overall remain at depressed prices, now's the time to build long-term positions in these seven cheap blue-chip stocks. More

Subscriber Sign in